Modi govt’s PLI schemes helping India make high-value drug as investors see profit

Aurobindo Pharma, Cipla, Dr. Reddy’s Laboratories, Glenmark, and Sun Pharma are among the top beneficiaries of the schemes, receiving incentives ranging from Rs 150 crore to Rs 330 crore

Dec 19, 2024 4

Modi govt’s PLI schemes helping India make high-value drug as investors see profit
Aurobindo Pharma, Cipla, Dr. Reddy’s Laboratories, Glenmark, and Sun Pharma are among the top beneficiaries of the schemes, receiving incentives ranging from Rs 150 crore to Rs 330 crore
Read More